台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-新百王 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

新百王 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/282.2100.592101.00100.500.21,7520.01%
2025/03/251106.5010105.30104.50-91,719-0.52%
2025/03/241106.0000.00105.5011,7140.06%
2025/03/2100.000106.00106.5001,7140.00%
2025/03/201105.5000.00106.0011,7130.06%
2025/03/192105.5000.00104.5021,7180.12%
2025/03/181106.001106.00106.5001,7130.00%
2025/03/1700.001106.00105.00-11,714-0.06%
2025/03/141105.5000.00105.0011,7130.06%
2025/03/1311104.553105.83103.5081,7070.47%
2025/03/121106.5000.00107.0011,6950.06%
2025/03/110106.5000.00107.0001,6970.00%
2025/03/101106.001107.50107.0001,6860.00%
2025/03/078109.191107.00107.5071,6650.42%
2025/03/061.2113.672111.00111.00-0.81,647-0.05%
2025/03/053115.003114.67115.5001,6450.00%
2025/03/032113.7500.00112.5021,6200.12%
2025/02/276.5111.352109.50109.004.51,5680.29%
2025/02/265117.0011116.68115.50-61,553-0.39%
2025/02/241114.5018.1114.31115.00-171,431-1.19%
2025/02/215112.8014112.64113.00-91,412-0.64%
2025/02/2000.0012109.50110.00-121,389-0.86%
2025/02/191110.5030109.57110.00-291,396-2.08%
2025/02/182110.501112.00110.0011,4010.07%
2025/02/1700.003114.50112.50-31,397-0.21%
2025/02/149111.062110.25111.5071,4080.50%
2025/02/1315111.4700.00111.50151,4131.06%
2025/02/1237111.051112.00112.00361,4082.56%
2025/02/1119111.6300.00109.00191,3921.36%
2025/02/101119.0000.00118.5011,3370.07%
2025/02/077118.215118.90120.5021,3510.15%
2025/02/064118.635.6120.07119.00-1.61,329-0.12%
2025/02/054109.755112.90113.00-11,194-0.08%
2025/02/0400.001104.00103.00-11,201-0.08%
2025/01/20193.6000.0093.6011,2790.08%
2025/01/1500.00193.9093.10-11,380-0.07%
2025/01/1300.00196.6096.30-11,370-0.07%
2025/01/10196.2000.0097.0011,3550.07%
2025/01/09195.10294.9594.60-11,341-0.07%
2025/01/071100.501101.50101.5001,2750.00%
2025/01/06199.801100.00101.5001,2590.00%
2025/01/0200.00293.9593.60-21,235-0.16%
2024/12/26192.50193.2092.5001,2250.00%
2024/12/25191.00289.5091.00-11,214-0.08%
2024/12/24187.40188.3087.4001,2070.00%
2024/12/23186.9000.0087.0011,2100.08%
2024/12/19187.3000.0087.4011,2100.08%
2024/12/18188.4000.0088.8011,2200.08%
2024/12/1700.00186.6086.70-11,223-0.08%
2024/12/13188.7000.0088.8011,2090.08%
2024/12/1100.00191.3090.60-11,193-0.08%
2024/12/02294.8000.0094.4021,1580.17%
2024/11/2000.00196.5096.50-11,018-0.10%
2024/11/1900.00496.2596.00-41,015-0.39%
2024/11/086.1103.8700.00103.006.18730.70%
2024/11/064106.504102.00102.5008260.00%
2024/11/0500.002107.50106.00-2782-0.26%
2024/11/043105.671.2102.54100.001.87580.24%
2024/11/015108.108.1106.23105.00-3.1730-0.42%
2024/10/294.1101.634100.20100.500.16040.01%
2024/10/285101.068.7101.86102.00-3.7576-0.64%
2024/10/252.198.2900.0097.402.15130.41%
2024/10/2414100.171398.7298.3014940.20%
2024/10/23187.8000.0093.7014240.24%
2024/10/1800.00287.0586.80-2450-0.44%
2024/10/17288.4500.0088.3024690.43%
2024/10/16189.80289.4089.40-1476-0.21%
2024/10/14189.0000.0089.2014980.20%
2024/10/1100.00289.5088.30-2502-0.41%
2024/10/0800.00090.3091.1005070.00%
2024/10/04088.8000.0088.7005410.00%
2024/09/2500.00088.9088.200609-0.01%
2024/09/2300.00088.0288.0006200.00%
2024/09/20088.30188.2087.40-1644-0.15%
2024/08/2000.00186.5085.80-1742-0.13%
2024/08/1600.00284.5584.60-2743-0.27%
2024/08/15184.5000.0084.5017450.13%
2024/08/14284.20183.5083.6017550.13%
2024/08/1300.00184.6084.40-1772-0.13%
2024/08/12185.1000.0084.9017800.13%
2024/08/07186.60184.3086.7007940.00%
2024/08/05583.06184.0083.0047640.52%
2024/08/0200.00092.5092.2007410.00%
2024/07/2600.00297.0097.60-2729-0.27%
2024/07/19397.07396.3094.2007080.00%
2024/07/18298.702.299.1799.40-0.2676-0.03%
2024/07/1700.00199.0098.20-1658-0.15%
2024/07/15198.5000.0098.4016630.15%
2024/07/09198.30196.3096.3006680.00%
2024/07/0800.001100.00100.50-1655-0.15%
2024/07/04096.1000.0096.0006260.00%
2024/06/26195.50197.0097.6005760.00%
2024/06/14195.4000.0095.3016550.15%
2024/06/060.191.9000.0091.100.16300.02%
2024/05/200.197.0000.0096.900.18650.01%
2024/05/1000.00193.0093.30-11,052-0.10%
2024/05/02094.1000.0094.9001,4140.00%
2024/04/29294.35294.6095.3001,4300.00%
2024/04/15295.60294.1094.1001,5650.00%
2024/04/09398.63597.8097.60-21,722-0.12%
2024/04/03197.60297.9099.00-11,777-0.06%
2024/04/0200.00099.6098.9001,7800.00%
2024/04/012100.151100.5099.6011,8050.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章